相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First Immunoassay for Measuring Isoaspartate in Human Serum Albumin
Jijing Wang et al.
MOLECULES (2021)
Albumin Alters the Conformational Ensemble of Amyloid-β by Promiscuous Interactions: Implications for Amyloid Inhibition
Huisi Xie et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Aging-induced isoDGR-modified fibronectin activates monocytic and endothelial cells to promote atherosclerosis
Jung Eun Park et al.
ATHEROSCLEROSIS (2021)
Multipronged Regulatory Functions of Serum Albumin in Early Stages of Amyloid-β Aggregation
Mengjuan Zhao et al.
ACS CHEMICAL NEUROSCIENCE (2021)
New Insights Into the Pathogenesis of Alzheimer's Disease
Liyuan Fan et al.
FRONTIERS IN NEUROLOGY (2020)
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies
Giovanni B. Frisoni et al.
ALZHEIMERS & DEMENTIA (2020)
Serum albumin and beta-amyloid deposition in the human brain
Jee Wook Kim et al.
NEUROLOGY (2020)
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions
A. A. D. T. Abeysinghe et al.
LIFE SCIENCES (2020)
The Role of Copper in Tau-Related Pathology in Alzheimer's Disease
Klara Zubcic et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
Andre L. B. Bitencourt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Fatty Acids Compete with Aβ in Binding to Serum Albumin by Quenching Its Conformational Flexibility
Cong Guo et al.
BIOPHYSICAL JOURNAL (2019)
Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease
Pol Picon-Pages et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers
Judith M. Silverman et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy
Shu-Hui Xin et al.
NEUROTOXICITY RESEARCH (2018)
Therapeutic potential for peripheral clearance of misfolded brain proteins
Mony J. de Leon et al.
NATURE REVIEWS NEUROLOGY (2018)
Impaired hepatic amyloid-beta degradation in Alzheimer's disease
Chera L. Maarouf et al.
PLOS ONE (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Tau Proteins Cross the Blood-Brain Barrier
William A. Banks et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease
Yong Kyoung Yoo et al.
SCIENTIFIC REPORTS (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model
Assaf Ezra et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Clearance of Amyloid-Beta in Alzheimer's Disease: Shifting the Action Site from Center to Periphery
Yu-Hui Liu et al.
MOLECULAR NEUROBIOLOGY (2015)
Structural and Kinetic Characterization of Guinea Pig L-Asparaginase Type III
Amanda M. Schalk et al.
BIOCHEMISTRY (2014)
Prognostic Polypeptide Blood Plasma Biomarkers of Alzheimer's Disease Progression
Hongqian Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
Jian-Zhi Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Degradation of tau protein by autophagy and proteasomal pathways
Yipeng Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Fibrinogen and Altered Hemostasis in Alzheimer's Disease
Marta Cortes-Canteli et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium IMPLICATIONS FOR ALZHEIMER DISEASE
Helen F. Stanyon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
Neha Sehgal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Stoichiometry and Affinity of the Human Serum Albumin-Alzheimer's Aβ Peptide Interactions
Julijana Milojevic et al.
BIOPHYSICAL JOURNAL (2011)
Alzheimer's Disease and Mild Cognitive Impairment are Associated with Elevated Levels of Isoaspartyl Residues in Blood Plasma Proteins
Hongqian Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Copper Transfer from Cu-Aβ to Human Serum Albumin Inhibits Aggregation, Radical Production and Reduces Aβ Toxicity
Lorena Perrone et al.
CHEMBIOCHEM (2010)
Serum Albumin Concentration and Cognitive Impairment
D. J. Llewellyn et al.
CURRENT ALZHEIMER RESEARCH (2010)
The Human Asparaginase-like Protein 1 hASRGL1 Is an Ntn Hydrolase with β-Aspartyl Peptidase Activity
Jason R. Cantor et al.
BIOCHEMISTRY (2009)
Human Serum Albumin Inhibits Aβ Fibrillization through a Monomer-Competitor Mechanism
Julijana Milojevic et al.
BIOPHYSICAL JOURNAL (2009)
Serum albumin levels predict cognitive impairment in elderly hip fracture patients
Eliyahu Hayim Mizrahi et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2008)
Isoaspartate residues dramatically influence substrate recognition and turnover by proteases
Livia Boehme et al.
BIOLOGICAL CHEMISTRY (2008)
Therapeutics for Alzheimer's disease based on the Metal Hypothesis
Ashley I. Bush et al.
NEUROTHERAPEUTICS (2008)
Altered immunogenicity of isoaspartate containing proteins
Hester A. Doyle et al.
AUTOIMMUNITY (2007)
Asparagine deamidation: pH-dependent mechanism from density functional theory
B Peters et al.
BIOCHEMISTRY (2006)
Decreased plasma antioxidants in patients with Alzheimer's disease
TS Kim et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Decline of immune responsiveness: A pathogenetic factor in Alzheimer's disease?
E Richartz et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
Protein degradation and protection against misfolded or damaged proteins
AL Goldberg
NATURE (2003)
Molecular clocks
NE Robinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Isoaspartate formation and neurodegeneration in Alzheimer's disease
T Shimizu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Protein aging hypothesis of Alzheimer disease
J Orpiszewski et al.
FASEB JOURNAL (2000)
分享论文
